1. Home
  2. RDY vs BWXT Comparison

RDY vs BWXT Comparison

Compare RDY & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • BWXT
  • Stock Information
  • Founded
  • RDY 1984
  • BWXT 1867
  • Country
  • RDY India
  • BWXT United States
  • Employees
  • RDY N/A
  • BWXT N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • BWXT
  • Sector
  • RDY Health Care
  • BWXT
  • Exchange
  • RDY Nasdaq
  • BWXT Nasdaq
  • Market Cap
  • RDY 11.9B
  • BWXT 10.9B
  • IPO Year
  • RDY N/A
  • BWXT N/A
  • Fundamental
  • Price
  • RDY $15.38
  • BWXT $113.25
  • Analyst Decision
  • RDY Buy
  • BWXT Strong Buy
  • Analyst Count
  • RDY 1
  • BWXT 8
  • Target Price
  • RDY $17.00
  • BWXT $124.57
  • AVG Volume (30 Days)
  • RDY 1.6M
  • BWXT 788.8K
  • Earning Date
  • RDY 01-28-2025
  • BWXT 11-04-2024
  • Dividend Yield
  • RDY 3.74%
  • BWXT 0.85%
  • EPS Growth
  • RDY 4.63
  • BWXT 24.26
  • EPS
  • RDY 0.76
  • BWXT 3.02
  • Revenue
  • RDY $3,579,112,656.00
  • BWXT $2,682,902,000.00
  • Revenue This Year
  • RDY $13.39
  • BWXT $9.56
  • Revenue Next Year
  • RDY $8.35
  • BWXT $6.33
  • P/E Ratio
  • RDY $20.68
  • BWXT $37.51
  • Revenue Growth
  • RDY 12.37
  • BWXT 12.02
  • 52 Week Low
  • RDY $13.41
  • BWXT $74.69
  • 52 Week High
  • RDY $16.89
  • BWXT $136.31
  • Technical
  • Relative Strength Index (RSI)
  • RDY 66.14
  • BWXT 29.62
  • Support Level
  • RDY $14.45
  • BWXT $121.26
  • Resistance Level
  • RDY $14.85
  • BWXT $124.86
  • Average True Range (ATR)
  • RDY 0.19
  • BWXT 3.10
  • MACD
  • RDY 0.13
  • BWXT -1.78
  • Stochastic Oscillator
  • RDY 88.17
  • BWXT 10.15

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

Share on Social Networks: